Biodesix, Inc. (BDSX)
28.58
-2.02
(-6.60%)
USD |
NASDAQ |
Aug 27, 16:00
28.58
0.00 (0.00%)
After-Hours: 19:14
Biodesix Debt to Equity Ratio : 7.852 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 7.852 |
| March 31, 2026 | 7.842 |
| December 31, 2025 | -29.56 |
| September 30, 2025 | -42.35 |
| June 30, 2025 | 63.39 |
| March 31, 2025 | 5.632 |
| December 31, 2024 | 2.969 |
| September 30, 2024 | 2.224 |
| June 30, 2024 | 1.699 |
| March 31, 2024 | -11.12 |
| December 31, 2023 | 13.25 |
| September 30, 2023 | -35.10 |
| June 30, 2023 | -6.438 |
| March 31, 2023 | 8.557 |
| Date | Value |
|---|---|
| December 31, 2022 | 1.546 |
| September 30, 2022 | -8.097 |
| June 30, 2022 | 3.205 |
| March 31, 2022 | 1.593 |
| December 31, 2021 | 0.5075 |
| September 30, 2021 | 1.871 |
| June 30, 2021 | 1.283 |
| March 31, 2021 | 0.9068 |
| December 31, 2020 | 0.6745 |
| September 30, 2020 | -0.2122 |
| June 30, 2020 | |
| March 31, 2020 | |
| December 31, 2019 | -0.1574 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| BillionToOne, Inc. | 0.2681 |
| Quest Diagnostics, Inc. | 0.8493 |
| Labcorp Holdings, Inc. | 0.7861 |
| OPKO Health, Inc. | 0.3362 |
| Psychemedics Corp. | -- |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 95.33M |
| Total Liabilities (Quarterly) | 86.18M |
| Shareholders Equity (Quarterly) | 9.144M |
| Current Ratio | 2.849 |
| Net Debt Paydown Yield | -0.80% |